Company intelligence / Profile preview

AzureDelta Consulting

Ownership: Private
Development stage: Commercial

Overview

AzureDelta Consulting provides expert consulting in clinical pharmacology and drug development for pharmaceutical and medical device companies. Led by Dr. Galina Bernstein, the firm has supported over three hundred studies across a wide range of therapeutic areas and modalities—including rare disease and advanced therapies such as gene therapy—offering services from biomarker analysis to regulatory strategy for IND/NDA submissions. The company does not develop its own drugs but supports clients' programs at all stages with integrated data analysis and regulatory expertise[1][4][5].

Therapeutic areas: NephrologyOncologyEndocrinologyImmunologyRare DiseasesDermatologyCardiovascularNeurologyInfectious Diseases
Modalities: Small moleculeGene therapyBiologicMedical deviceVaccinePeptidesProtein
Industry: Consulting

Beyond the preview

Go deeper on AzureDelta Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AzureDelta Consulting.

Explore the full profile